Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Purpose
The study is an observational multicenter evaluation of participants with colorectal cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition to their standard-of-care therapy and disease surveillance.
Condition
- Colorectal Cancer
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Known or suspected colorectal adenocarcinoma (Stage I to IVA disease) - Planning to undergo or has undergone a surgical resection for suspected adenocarcinoma of the colon or rectum with curative intent. - 18 years old or older - Willing and able to provide informed consent - Willing to have additional blood samples collected during routine surveillance visits
Exclusion Criteria
- Not willing to have additional blood samples collected - Pathology that is not consistent with colorectal adenocarcinoma
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Case-Only
- Time Perspective
- Prospective
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| Participants with stage I-IV colorectal cancer (CRC) | This protocol will include participants with stage I-IV CRC who are scheduled to undergo or have undergone a surgical resection with curative intent. |
|
Recruiting Locations
Fort Smith, Arkansas 72903
Fountain Valley, California 92708
Bethesda, Maryland 20817
Joplin, Missouri 64804
Springfield, Missouri 65804
St Louis, Missouri 63110
St Louis, Missouri 63128
St Louis, Missouri 63141
Omaha, Nebraska 68130
Goldsboro, North Carolina 27543
Cincinnati, Ohio 45220
Columbus, Ohio 43214
Toledo, Ohio 43623
Oklahoma City, Oklahoma 73120
York, Pennsylvania 17403
Salt Lake City, Utah 84124
Seattle, Washington 98109
Appleton, Wisconsin 54911
More Details
- NCT ID
- NCT05234177
- Status
- Recruiting
- Sponsor
- Tempus AI